These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 31661838)

  • 1. Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP
    Kawahata I; Bousset L; Melki R; Fukunaga K
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of fatty acid-binding proteins and dopamine receptors on α-synucleinopathy.
    Kawahata I; Fukunaga K
    J Pharmacol Sci; 2022 Feb; 148(2):248-254. PubMed ID: 35063140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of FABP3 ligands that inhibit arachidonic acid-induced α-synuclein oligomerization.
    Cheng A; Shinoda Y; Yamamoto T; Miyachi H; Fukunaga K
    Brain Res; 2019 Mar; 1707():190-197. PubMed ID: 30496735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain.
    Yabuki Y; Matsuo K; Kawahata I; Fukui N; Mizobata T; Kawata Y; Owada Y; Shioda N; Fukunaga K
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D2 Long Receptors Are Critical for Caveolae-Mediated α-Synuclein Uptake in Cultured Dopaminergic Neurons.
    Kawahata I; Sekimori T; Wang H; Wang Y; Sasaoka T; Bousset L; Melki R; Mizobata T; Kawata Y; Fukunaga K
    Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33429895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of MPTP-induced α-synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice.
    Matsuo K; Cheng A; Yabuki Y; Takahata I; Miyachi H; Fukunaga K
    Neuropharmacology; 2019 May; 150():164-174. PubMed ID: 30930168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FABP3 protein promotes α-synuclein oligomerization associated with 1-methyl-1,2,3,6-tetrahydropiridine-induced neurotoxicity.
    Shioda N; Yabuki Y; Kobayashi Y; Onozato M; Owada Y; Fukunaga K
    J Biol Chem; 2014 Jul; 289(27):18957-65. PubMed ID: 24855640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of α-synuclein propagation after intrastriatal injection in FABP3 null mice.
    Matsuo K; Kawahata I; Melki R; Bousset L; Owada Y; Fukunaga K
    Brain Res; 2021 Jun; 1760():147383. PubMed ID: 33636166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel FABP3 ligand, HY-11-9, ameliorates neuropathological deficits in MPTP-induced Parkinsonism in mice.
    Wang H; Fukunaga K; Cheng A; Wang Y; Arimura N; Yoshino H; Sasaki T; Kawahata I
    J Pharmacol Sci; 2023 May; 152(1):30-38. PubMed ID: 37059489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease.
    Ryan BJ; Lourenço-Venda LL; Crabtree MJ; Hale AB; Channon KM; Wade-Martins R
    Free Radic Biol Med; 2014 Feb; 67():58-68. PubMed ID: 24148766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
    Zhai A; Zhu X; Wang X; Chen R; Wang H
    Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease.
    Wang X; Su B; Liu W; He X; Gao Y; Castellani RJ; Perry G; Smith MA; Zhu X
    Aging Cell; 2011 Oct; 10(5):807-23. PubMed ID: 21615675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An α-synuclein decoy peptide prevents cytotoxic α-synuclein aggregation caused by fatty acid binding protein 3.
    Fukui N; Yamamoto H; Miyabe M; Aoyama Y; Hongo K; Mizobata T; Kawahata I; Yabuki Y; Shinoda Y; Fukunaga K; Kawata Y
    J Biol Chem; 2021; 296():100663. PubMed ID: 33862084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel fatty acid-binding protein 3 ligand inhibits dopaminergic neuronal death and improves motor and cognitive impairments in Parkinson's disease model mice.
    Haga H; Yamada R; Izumi H; Shinoda Y; Kawahata I; Miyachi H; Fukunaga K
    Pharmacol Biochem Behav; 2020 Apr; 191():172891. PubMed ID: 32126223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins.
    Callizot N; Combes M; Henriques A; Poindron P
    PLoS One; 2019; 14(4):e0215277. PubMed ID: 31022188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death.
    Kaul S; Anantharam V; Kanthasamy A; Kanthasamy AG
    Brain Res Mol Brain Res; 2005 Sep; 139(1):137-52. PubMed ID: 15978696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium entry and α-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons.
    Dryanovski DI; Guzman JN; Xie Z; Galteri DJ; Volpicelli-Daley LA; Lee VM; Miller RJ; Schumacker PT; Surmeier DJ
    J Neurosci; 2013 Jun; 33(24):10154-64. PubMed ID: 23761910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin.
    Lieberman OJ; Choi SJ; Kanter E; Saverchenko A; Frier MD; Fiore GM; Wu M; Kondapalli J; Zampese E; Surmeier DJ; Sulzer D; Mosharov EV
    eNeuro; 2017; 4(6):. PubMed ID: 29177188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crucial Role of FABP3 in αSyn-Induced Reduction of Septal GABAergic Neurons and Cognitive Decline in Mice.
    Matsuo K; Yabuki Y; Melki R; Bousset L; Owada Y; Fukunaga K
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of methylmercury on dopamine release in MN9D neuronal cells.
    Shao Y; Chan HM
    Toxicol Mech Methods; 2015; 25(8):637-44. PubMed ID: 26056851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.